Pathbreakers: The journey of first generics
Pharmaceutical Technology
MAY 3, 2023
In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu. However, that percentage of multiple first generics is not very high—approximately 10.6% from 2001 to 2022.”
98 
Let's personalize your content